Year: 2015

ISPOR 18th ANNUAL EUROPEAN CONGRESS ISSUE PANEL EXPLORES ROLE OF ECONOMIC EVALUATION IN PRICING & REIMBURSEMENT OF MEDICINES

SESSION COMPARES ENGLAND, GERMANY, AND FRANCE  Milan, Italy—November 9, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual European Congress Issue Panel 1 explored, “What Is the Role of Economic Evaluation in Pricing and Reimbursement of

Posted in Announcements, ISPOR News & Press Tagged with: , ,

ISPOR’s 1st PLENARY OF 18th ANNUAL EUROPEAN CONGRESS FOCUSES ON LIFECYCLE APPROACH TO DECISION MAKING ON HEALTH TECHNOLOGIES

Milan, Italy—November 9, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual European Congress first plenary session — Strategy in Motion: The Current and Future

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , ,

ISPOR EUROPEAN CONGRESS FOCUSES ON “IMPACTING HEALTH DECISION MAKING WITH OUTCOMES RESEARCH”

18th ANNUAL CONGRESS TO BE HELD 7-11 NOVEMBER, 2015 IN MILAN, ITALY  Princeton, NJ—November 2, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced confirmation of key scientific sessions for its 18th Annual European Congress starting next week, 7-11

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , , , , , ,

INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS AND OUTCOMES RESEARCH (ISPOR) EXPANDS LEADERSHIP TEAM

BETSY LANE JOINS ISPOR AS CHIEF MARKETING & COMMUNICATIONS OFFICER  Princeton, NJ—October 28, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced that Betsy Lane has been appointed director and chief marketing and communications officer for the organization. Lane

Posted in Announcements, ISPOR News & Press Tagged with: ,

STUDY REVEALS SIGNIFICANT GLOBAL VARIATION IN THE DEFINITION OF THE TERM “RARE DISEASE”

First International Study of Its Kind Published in ISPOR’s Value in Health  Princeton, NJ—October 26, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published results of an expansive global review answering a basic scientific question, “How do you describe

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , , ,

ISPOR ANNOUNCES CALL FOR NOMINATIONS

SUBMISSIONS BEING ACCEPTED FOR 2016-2017 BOARD OF DIRECTORS Princeton, NJ—October 19, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today that it is

Posted in Announcements, ISPOR News & Press Tagged with: , , , ,

ATLAS AWARD TO BE PRESENTED TO AUTHORS OF ISPOR’s VALUE IN HEALTH ARTICLE

ARTICLE MAINTAINS THAT UNIVERSAL HEALTH CARE SYSTEMS SHOULD ALSO FOCUS ON SOCIAL AND POLITICAL SUSTAINABILITY AND NOT SOLELY ON FINANCE Princeton, NJ—October 15, 2015—The Elsevier Atlas Award will be presented to the authors of a Value

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , , ,

ISPOR 18th ANNUAL EUROPEAN CONGRESS REGISTRATION AT RECORD HIGH

Princeton, NJ—October 13, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today that its 18th Annual European Congress has registered a record number of delegates for this annual meeting. The Congress will be held 7-11 November 2015 in

Posted in Announcements, ISPOR News & Press Tagged with: , , , ,

COST OF DIABETES MELLITUS – IS EARLY DIAGNOSIS A SAVIOR?

Accra, Ghana – The number of diabetes cases and the associated health care budget has been increasing worldwide. It has thus become a growing public health burden for patients, health care providers, and society. The cost of diabetes study has

Posted in Health Policy Analyses, ISPOR News & Press, Value in Health Regional Issues Tagged with: , , , , ,